ASTRO 2017: QOL Outcomes Among Prostate Cancer Treatment Options
This video reviews 4-year quality-of-life results from a prospective, population-based study that looked at prostate cancer patients who selected either active surveillance, radical prostatectomy, or external-beam radiation.
In this video, Ronald C. Chen, MD, MPH, of the University of North Carolina Lineberger Comprehensive Cancer Center in Chapel Hill, discusses a prospective, population-based study examining 4-year quality-of-life results among prostate cancer patients who were treated with either active surveillance, radical prostatectomy, or external-beam radiation.
Chen presented results of the study (abstract LBA-11) at the 2017 American Society for Radiation Oncology (ASTRO) Annual Meeting, held September 24–27 in San Diego.
Navigating Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer
A patient case of a 50-year-old man with hormone-sensitive prostate cancer sparked a debate among oncologists regarding the best course of action.
